PDI introduces new swab

Share this content:
PDI introduces new swab
PDI introduces new swab

PDI has debuted the Prevantics® Device Swab, a chlorhexidine gluconate/alcohol solution that has received market authorization from the U.S. Food and Drug Administration for disinfecting needleless access sites prior to use on ports and hubs.

The swab features a 3.15% Chlorhexidine Gluconate (w/v) and 70% Isopropyl Alcohol (v/v) formulation. It is part of the Prevantics® skin antiseptics line, which includes the 1.0 mL Swab, 1.6 mL Swabstick and 5.1 mL Maxi-Swabstick designed for preoperative and pre-injection skin preparation. 

close

Next Article in Products